Tert-Butyl-2H-Pyrrole-1(5H)-Carboxylate

Upon charging a 5,000 L Hastelloy B jacketed stirred autoclave with a de‑oxygenated solution of tert‑butyl 2H‑pyrrole‑1(5H)‑carboxylate in anhydrous tetrahydrofuran (THF, water content <300 ppm by Karl Fischer titrimetry, USP ⟨921⟩), the rhodium precatalyst [Rh(COD)₂]BF₄ (0.02 mol%) and (R,R)‑Et‑DuPhos (0.022 mol%) are combined in a nitrogen‑flushed high‑pressure catalyst addition bomb. Pre‑activation proceeds under a static H₂ blanket at 3.0 ± 0.2 bar (absolute) for 25–35 min at 20–25 °C until the solution darkens from yellow to deep orange, signalling active rhodium‑hydride species formation. The activated stream is injected into the substrate‑containing autoclave under positive nitrogen pressure to eliminate oxygen ingress. Hydrogen is supplied via a Brooks SLA5800 mass flow controller calibrated to ISO 17025, ramping to a target pressure of 12.0 bar (g) at a rate not exceeding 0.5 bar·min⁻¹ to prevent overshoot. Exothermic release of approximately −95 to −110 kJ·mol⁻¹ necessitates jacket cooling with a refrigerant mix set to 5 °C; a deviation above 35 °C bulk temperature triggers an interlock to vent hydrogen and quench with nitrogen. End‑point is determined by on‑line Raman spectroscopy monitoring the disappearance of the endocyclic alkene band at 1658 cm⁻¹. Full conversion typically completes within 8–14 h. Upon cooling and venting, the crude mixture is filtered through a 0.5 micron sintered‑metal candle filter to recover spent catalyst, then passed through a packed column of QuadraSil AP scavenger resin (40 g·L⁻¹ bed loading) to reduce residual rhodium below <5 ppm as measured by ICP‑MS per USP ⟨233⟩. The batch is concentrated in a wiped‑film evaporator operating at 40 °C and 150 mbar to a syrup, then crystallised from n‑heptane/methyl tert‑butyl ether (4:1 v/v) at ‑5 °C over 6 h. Product is isolated by a centrifuge with 0.2 µm cloth, washed with cold heptane, and dried in a double‑cone vacuum dryer at 35 °C and 5 mbar for 12 h. The (R)‑N‑Boc‑3‑hydroxypyrrolidine typically exhibits a purity of >99.8% by GC (DB‑5 column, 30 m × 0.32 mm ID, 0.25 µm film, flame ionisation detection) and an enantiomeric excess of >99.5% determined on a Chiralpak IG‑3 (4.6 × 250 mm, 5 µm) eluting with n‑hexane/isopropanol/diethylamine 90:10:0.1 at 1.0 mL·min⁻¹, UV 215 nm. This building block is directly converted to sitagliptin‑type dipeptidyl peptidase‑4 inhibitors via subsequent Mitsunobu chemistry or reductive amination steps documented in pharmacopoeial monographs (e.g., European Pharmacopoeia 10.0, 01/2023:2771). Operational boundaries: The substrate must be stored under nitrogen at <10 °C to prevent autoxidation‑derived epoxide formation; exposure to ambient air for more than 4 h results in a colour drift to dark brown and an impurity level exceeding 0.3% that is recalcitrant to downstream chiral purification. The hydrogenation catalyst system is exceptionally sensitive to chloride‑containing solvents and iron‑contaminated reactor walls, which can drop enantiomeric excess to 68–75% and require a vessel passivation protocol using 10% aqueous nitric acid at 60 °C prior to campaign.

Does Hydroborative Work‑Up Interfere with Boc Stability on Plant Scale?

While asymmetric hydrogenation dominates the patent literature, the hydroboration‑oxidation route to N‑Boc‑3‑hydroxypyrrolidine retains utility for smaller, high‑value batches where rapid ligand screening is required. In a 200 L glass‑lined reactor cooled to -15 °C with a Diabon‑graphite rupture disc, a 1.5 M solution of tert‑butyl 2H‑pyrrole‑1(5H)‑carboxylate in degassed 2‑methyltetrahydrofuran is treated with borane‑tetrahydrofuran complex (BH₃·THF, 1.05 eq.) dosed via a Bronkhorst Coriolis mass flow controller over 90 min. The adiabatic temperature rise must remain below -5 °C; excursion beyond 0 °C initiates premature oxidation of the organoborane intermediate and leads to a sharp pH drop during subsequent work‑up that cleaves the Boc group, generating isobutylene and carbon dioxide back‑pressure. After 3 h ageing at -10 to -5 °C, the reaction mass is transferred through a static mixer into a quench vessel containing 15% aqueous sodium hydroxide and 30% hydrogen peroxide pre‑chilled to 2 °C, sustaining a delicate pH 9.5–10.5 window monitored in‑line by a Mettler Toledo InPro 3250SG electrode. The exotherm drives the mixture to 40–45 °C, where the Boc group shows measurable lability—TGA‑MS of the isolated product batch standard reveals 1.2% weight loss onset at 48 °C due to partial decarboxylation. Consequently, the quench duration is limited to exactly 15 min after full peroxide addition, followed by immediate cooling to 10 °C and liquid‑liquid extraction with methylene chloride. The organic layer is washed with a 5% sodium metabisulfite solution to destroy residual peroxides, dried over anhydrous magnesium sulfate, and concentrated on a rotary evaporator maintaining a bath temperature not above 30 °C. The crude oil is then purified by short‑path vacuum distillation (jacket 95 °C, vacuum 0.5 mbar) to give the racemic product, which is subsequently resolved via diastereomeric salt formation with R‑mandelic acid in isopropanol. Handling note: the peroxides present during oxidative work‑up represent a potential Class‑5 explosion risk per ASTM E1226‑19, mandating online FTIR monitoring for peroxide functional groups at 830–860 cm⁻¹. Residual peroxide in the final product must be <50 ppm (Quantofix test strips, limit of detection) before release.

Cyclopropanation / Ring‑Opening Cascades for NS5A Antiviral Chemotypes

An under‑appreciated application of the N‑Boc‑protected 2,5‑dihydropyrrole scaffold lies in the preparation of HCV NS5A replication complex inhibitors, where a conformationally constrained pyrrolidine motif delivers profound gains in target binding potency. The endocyclic olefin is subjected to Simmons‑Smith cyclopropanation under strictly anhydrous conditions. In a 1,000 L Schlenk‑type vessel purged to residual oxygen <0.5 vol% (ISO 8573-1 Class 2), diethylzinc (2.2 eq., 1.0 M in hexanes) and diiodomethane (2.5 eq.) are pre‑complexed at 0 °C in dichloromethane (15 L·kg⁻¹ substrate) for 1 h before a 1.0 M solution of tert‑butyl 2H‑pyrrole‑1(5H)‑carboxylate is metered in over 4 h. The reaction discharges methane and ethylene as off‑gas; the mass‑flow signature of these gases, tracked by an Emerson CT5800 analyser, provides real‑time rate data for carbenoid consumption. The internal temperature is clamped at 0 to 5 °C; a spike above 10 °C accelerates Wurtz‑type homocoupling and forms a non‑distillable dimer impurity that reduces isolated yield by 12–18%. After 16 h, the batch is quenched with saturated ammonium chloride at 5 °C, the organic layer is washed with saturated sodium thiosulfate to decolourise iodine, and the solvent is swapped to methanol for crystallisation of (1R,5S)‑tert‑butyl 3‑azabicyclo[3.1.0]hexane‑3‑carboxylate. Typical yields fall in the range 85–92% with a chromatographic purity of 99.1% by HPLC (C18, acetonitrile/water gradient). Ring‑opening of the cyclopropyl ring with hydrogen over Pd/C (5% loading, 4 bar H₂, 25 °C, 8 h) furnishes disubstituted pyrrolidines that map onto the macrocyclic core of elbasvir analogues. Residual diiodomethane and heavy metals are controlled to ICH M7 mutagenic impurity thresholds; any batch exceeding 1.5 µg/day total lifetime intake is re‑processed via charcoal filtration and vacuum stripping.

If Continuous‑Flow Hydrogenation is Retrofitted to Existing Multipurpose Plants

Retrofitting a modular continuous‑flow hydrogenation skid—such as a ThalesNano H‑Cube Pro connected to a Corning G1 Advanced‑Flow Reactor—onto an existing multi‑purpose plant unlocks a processing window that batch autoclaves cannot match for tert‑butyl 2H‑pyrrole‑1(5H)‑carboxylate. The substrate is dissolved in anhydrous THF at 0.6 M and blended with hydrogen in a 500 µL micromixer at a gas‑to‑liquid volumetric ratio of 4:1 under 35 bar system pressure, before passing through a cartridge packed with 5% Rh/Al₂O₃ (E21137, Johnson Matthey) at a liquid hourly space velocity of 1.8 h⁻¹. The fixed‑bed catalyst cartridge dissipates the reaction enthalpy (ΔH ≈ −105 kJ·mol⁻¹) via a surrounding heat‑transfer oil channel held at 28±1 °C; thermocouples embedded at the inlet, midpoint and outlet of the bed record a thermal gradient no wider than 2.5 °C, compared with 8–12 °C excursions typical of a 500 gal stirred tank. Conversion exceeds 99.9% at the reactor exit as measured by in‑line UV‑Vis absorbance at 215 nm, rising to full consumption when a back‑pressure regulator (Equilibar ZF precision) maintains outlet pressure above 30 bar. Process safety: the intrinsic quench ability of the flow cell limits the flammable inventory to 20 mL of solvent‑vapour mixture, eliminating the need for a blast‑rated enclosure (ATEX Zone 0 substitute, reviewed under IEC 60079‑10‑1). The product stream is collected into a receiving vessel under nitrogen and directly stirred with a Polystyrene‑bound thiourea scavenger (10 wt%) to lower residual rhodium below 1 ppm. The main drawbacks involve initial capital expenditure for the skid and the requirement for filtered substrate pre‑treatment down to 0.2 µm to prevent catalyst bed fouling, adding €18–22 per kilogram at 1 metric ton annual volume.

Palladium‑Catalysed C–N Bond Construction Leverages the Allylic Acetate Derivative

Conversion of tert‑butyl 2H‑pyrrole‑1(5H)‑carboxylate into its 3‑aminopyrrolidine congener proceeds through an allylic bromination‑amination sequence that has become a workhorse in discovery‑scale contract manufacturing for neuroscience clinical candidates. The neat liquid substrate is diluted with carbon tetrachloride (8 L·kg⁻¹), charged with 1.02 eq. of recrystallised N‑bromosuccinimide (water content <0.1%), and heated to 77 °C under a high‑purity nitrogen sweep to evacuate generated hydrogen bromide. Radical initiation is accomplished with 0.5 mol% azobisisobutyronitrile added in three equal portions over 2 h to maintain a steady concentration of succinimidyl radicals; a single‑charge addition at the onset frequently triggers a runaway radical burst that yields dibrominated by‑products exceeding 8%. After total consumption of the olefin (6 h, monitored by TLC on silica gel 60 F₂₅₄, cyclohexane/ethyl acetate 4:1), the mixture is cooled, filtered, and concentrated to an oil that is immediately subjected to Pd‑catalysed amination. The crude 3‑bromo intermediate (70 kg scale) is dissolved in toluene and treated with lithium bis(trimethylsilyl)amide (1.3 eq., 1.0 M in THF) in the presence of Pd₂(dba)₃·CHCl₃ (1.0 mol%) and Xantphos (1.5 mol%) at 80 °C for 12 h, generating the N‑Boc‑3‑aminopyrrolidine scaffold after a dilute hydrochloric acid work‑up that removes silyl ether by‑products. The free amine is then locked into a salt form without isolation of the neutral pyrrolidine, which is prone to dimerisation at ambient temperature through aza‑Michael addition to residual conjugation products. Acid selection is dictated by the downstream convergent step; Table 2 compiles the deblocking protocols validated on 100 kg scale. Each method is qualified against USP ⟨231⟩ heavy metal limits and USP ⟨467⟩ residual solvent classes. Care must be taken to quench any residual isobutylene off‑gas into an aqueous scrubbing system because local emission limits (e.g., German TA‑Luft) cap C₄ hydrocarbon venting at 20 mg carbon per cubic metre.